The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dabigatran Etexilate Accord

Accord Healthcare S.L.U.EU/1/22/1665/017-027

Main Information

Trade NameDabigatran Etexilate Accord
Active SubstancesDabigatran etexilate mesilate
Dosage FormCapsule, hard
Licence HolderAccord Healthcare S.L.U.
Licence NumberEU/1/22/1665/017-027

Group Information

ATC CodeB01AE07 dabigatran etexilate


License statusAuthorised
Licence Issued26/05/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - HCP

Educational Materials - Patient

« Back